⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ADXN News
Addex Therapeutics Ltd American Depositary Shares
Addex Announces Publication of Preclinical Data Supporting Potential of mGlu7 Negative Allosteric Modulators to Transform Anxiety and Fear-Related Disorder Treatment
globenewswire.com
ADXN
Addex Spin-Out Neurosterix has started a Phase 1 Clinical Study with M4 PAM - NTX-253 for Schizophrenia
globenewswire.com
ADXN
Addex Amends its at the Market Offering Agreement With H.C. Wainwright & Co.
globenewswire.com
ADXN
Addex Therapeutics Reports 2025 Third Quarter Financial Results and Provides Corporate Update
globenewswire.com
ADXN
Addex Therapeutics to Report 2025 Third Quarter Financial Results And Host Conference Call on December 4, 2025
globenewswire.com
ADXN